key: cord-0707437-ua1h5fgg
authors: fengmin, Shaohao; Zhang, Hongtao; Zhu, Guizhen; Yan, Lei; Lu, Yang; Fang, Qiying
title: The absorbing filter Oxiris in severe COVID‐19 patients: A case series
date: 2020-07-22
journal: Artif Organs
DOI: 10.1111/aor.13786
sha: b4c5319f95bb8a7e46a0e18e9f792f3b649559c6
doc_id: 707437
cord_uid: ua1h5fgg

OBJECTIVE: Hypercytokines cause acute respiratory distress syndrome (ARDS) in COVID‐19 patients, which is the main reason for ICU treatment and the leading cause of death in COVID‐19 patients. Cytokine storm is a critical factor in the development of ARDS. This study evaluated the efficacy and safety of Oxiris filter in the treatment of COVID‐19 patients. MATERIALS AND METHODS: Five patients with COVID‐19 who received CRRT in Henan provincial people's hospital between January 23, 2019, and March 28, 2020, were enrolled in this study. Heart rate (HR), mean arterial pressure (MAP), oxygenation index (PaO(2)/FiO(2)), renal function, C‐reactive protein (CRP), cytokines, procalcitonin (PCT), acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ), sequential organ failure score (SOFA) and prognosis were compared after CRRT. RESULTS: Five COVID‐19 patients, 3 males and 2 females, aged (70.2±19.6) years, were enrolled. After treatment, HR (101.4±14.08 vs 83.8±6.22 bpm/min), CRP (183±25.21 vs 93.78±70.81 mg/L), IL‐6 (3234.49 (713.51,16038.36) vs 181.29 (82.24,521.39) pg/ml), IL‐8 (154.86 (63.97,1476.1) vs 67.19 (27.84,85.57) pg/ml), and IL‐10 (17.43 (9.14,41.22) vs 4.97 (2.39, 8.70) pg/ml), APACHE Ⅱ (29±4.92 vs. 18.4±2.07), SOFA (17.2±1.92 vs. 11.2±3.4) significantly decreased (p < 0.05), while MAP (75.8±4.92 vs. 85.8±6.18 mmHg), PaO(2)/FiO(2) (101.2±7.49 vs. 132.6±26.15 mmHg) significantly increased (p < 0.05). Among the 5 patients, negative conversion of nucleic acid test was found in 3 cases, while 2 cases died. No adverse events occurred during the treatment. CONCLUSION: Our study observed a reduced level of overexpressed cytokines, stabilization of hemodynamic status, and staged improvement of organ function during the treatment with Oxiris filter.

COVID-19 broke out in Wuhan, China, in December 2019 and rapidly spread to more than 185 countries worldwide. By May 26, 2020, about 5.5 million confirmed cases with COVID-19 were reported in the world, resulting in a public health emergency of international concern and posing a serious threat to global public health security [1, 2] .The overall population is generally susceptible, and COVID-19 patients with chronic underlying diseases tend to quickly develop severe and critical forms of the disease, presenting with acute respiratory distress syndrome, septic shock, intractable metabolic acidosis, coagulation dysfunction, and multiple organ failure [3] . The mortality in severe patients is as high as 49%.

The rapid deterioration of conditions in severe patients is closely associated with cytokine storm-induced sepsis/septic shock, which are the leading causes of death in critical patients [4] . At present, organ support therapy is the main treatment for severe COVID-19 patients. Accordingly, continuous renal replacement therapy (CRRT), which is a widely used organ support therapy technology, has been widely used in acute respiratory distress syndrome coronavirus (SARS-CoV), middle east respiratory distress syndrome coronavirus (MERS-CoV) and other coronavirus associated pneumonia [5, 6] . The expert consensus on diagnosis and treatment of patients with severe and critical COVID-19 suggests that CRRT treatment, which can regulate the unbalanced inflammatory response, correct the immune disorder, and improve the clinical symptoms of severe patients, should be given when necessary.

Oxiris is a new generation of extracorporeal blood purification filters, which has good adsorption function of cytokines and endotoxins, as well as a routine renal support function of the CRRT filter and has an improvement effect on hemodynamics, metabolism and respiratory response [7] . At present, there have been no reports of Oxiris in the treatment of severe COVID-19 patients. The purpose of this study was to provide new ideas and inspirations for the treatment of severe COVID-19 patients. The clinical characteristics and outcomes of 5 severe COVID-19 patients who received CRRT with Oxiris filter were retrospectively analyzed.

This article is protected by copyright. All rights reserved This retrospective study included 5 patients (43-89 years old) with COVID-19 who were admitted to Henan provincial people's hospital between January 23, 2020, and March 28, 2020, and met the diagnostic criteria of critical COVID-2019 [ 2 ] . Patients who discontinued or abandoned treatment, patients with chronic organ failure (including hemodialysis for chronic renal dysfunction), intracranial hemorrhage or other uncontrollable hemorrhagic diseases, organ transplantation or hematological malignancy, pregnant or lactating women, patients with positive human immunodeficiency virus (HIV) and patients with suspected active tuberculosis, were excluded. In line with the medical ethics standards, with the approval of the ethics committee of Henan Provincial People's hospital , the signed informed consent was obtained from patients' families for all treatments.

Blood and secretion cultures were obtained from all patients, who were given antiviral, antibacterial, traditional Chinese medicine and other drug treatments, hemodynamic monitoring and treatment (capacity reactivity assessment, use of vasoactive drugs, severe ultrasound examination) and ventilator assisted ventilation, etc. 

Citrate regional anticoagulation or heparin anticoagulant regimens were adopted, and the anticoagulant doses were individually adjusted according to the patients' coagulation state.

Anticoagulation of unfractionated heparin: the initial dose was 20-30 mg, the additional dose was 8-15 mg / h, which decreased with the extension of treatment time, and the extra dose was stopped 30-60 min before the end of the treatment. In patients with regional citrate anticoagulation, a sterile citrate-containing solution without calcium was infused in predilution mode. In post-dilution, a sterile saline solution containing calcium chloride was infused to maintain postfilter Ca++ 0.25-0.35 mmol/L, arterial line Ca++ 1-1.5 meq/L.

This article is protected by copyright. All rights reserved

The clinical and biochemical indexes, acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ), sequential organ failure score (SOFA), continuous monitoring of the mean arterial pressure (MAP), heart rate (HR), blood gas analysis, oxygenation index (PaO 2 /FiO 2 ), C-reactive protein (CRP), calcitonin (PCT) and anteroposterior chest radiograph of all patients before and after Oxiris treatment were recorded, and enzyme-linked immunosorbent assay (ELISA) kit (eBioscience company, USA) was used to measure plasma levels of IL-1 β, IL-4, IL-6, IL-8, IL-10 and TNF -α.

SPSS 19.0 software was used for statistical analysis. The measurement data conforming to normal distribution were expressed by mean ± standard deviation, while those not conforming to normal distribution were expressed by the median + interquartile range. The comparison of data before and after treatment was performed by paired t-test or nonparametric test. P < 0.05 was considered statistically significant.

A total of 5 patients (including 3 males and 2 females) with severe COVID-19 combined with septic shock, with an average age of (70.2±19.6) years old, were treated with CRRT by Oxiris filter between January 23, 2020, and March 8, 2020. The average time of Oxiris initiation was (21.6±19.2) h, the average treatment time was (172.8±82.1) h, and the average use of filters was (7.2±3.4) sets. All patients were treated with auxiliary ventilation, where 2 patients with extracorporeal membrane oxygenation (ECMO) survived. Regional citrate was used for anticoagulation in 2 cases, and heparin was used for anticoagulation in 3 cases. During this period, the transmembrane pressure (TMP) and 

This article is protected by copyright. All rights reserved 

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/AOR.13786

This article is protected by copyright. All rights reserved Table 1 ) After Oxiris treatment, the level of IL-1 β, IL-6, IL-10, and CRP significantly decreased (P < 0.05), while the level of IL-4, IL-8, and PCT decreased after treatment, but there was no significant difference (Table 2) .

After Oxiris treatment, HR significantly decreased while PaO 2 /FiO 2 significantly increased (P<0.05). During the treatment, the improvement of MAP and lactate was consistent with the improvement of PaO 2 /FiO 2 (Table 3) .

After Oxiris treatment, APACHE Ⅱ and SOFA scores significantly decreased (P<0.05). At the same time, serum creatinine and D-Dimer also showed a downward trend, although without significant difference after treatment compared with that before (Table 4 ).

COVID-19 is an epidemic of global concern. Although the fatality rate of infection caused by coronavirus is lower than that caused by other coronaviruses, and most patients only show mild flu symptoms or no symptoms, it has strong infectivity [8] . The significant difference between COVID-19

and previous viral pneumonia and SARS is that some patients have mild early symptoms and the condition suddenly aggravates and rapidly deteriorates in the 2 nd to 3 rd week of the course of the disease, with 13.8% patients develop the severe type of the disease and 4.7% patients develop critical type [9] . Previous studies have pointed out the cytokine storms as a possible cause of aggravation [ 8 ] .

Cytokine storm is a systemic inflammatory reaction that releases a series of cytokines, including TNF-α, IL-1 β, IL-2, IL-6, IFN -α, and MCP-1. These cytokines induce immune cells to release large amounts of free radicals, which are the leading cause of ARDS and multiple organ failure [10] .

Approximately 67% of critical COVID-19 patients experienced multiple organ failures, which were, to some extent, cytokine storm-induced [11] . The indexes of inflammatory factors (IL-1 β, IL-4, IL-6, IL-8, IL-10, TNF -α) in the five enrolled patients in this study were consistent with previous reports, which were significantly higher than normal, suggesting the occurrence of cytokine storm and the critical condition of patients. Blood purification therapy is considered as an important means for removing cytokines from patients with sepsis and also the main advocated technology of organ support therapy for patients with severe COVID-19.

This article is protected by copyright. All rights reserved

Oxiris is a new generation of CRRT filter of blood purification membrane material, which is modified on the surface of AN69 (polyacrylonitrile) basement membrane and has the functions of supporting renal function, adsorbing endotoxin and removing inflammatory mediators [12] . We observe a sharp decrease of most inflammatory factors (IL-6, IL-1β, IL-8, IL-10) which extraordinary increased before CRRT, and is in accordance with previous studies [13] . The overall value of PCT and TNF-α showed an upward trend, which is inconsistent with existing studies [13, 14] . However, we found that there was only one case whose value of PCT substantial increased after CRRT, which may be associated with uncontrolled exacerbation of secondary infection, therefore, we assume that the upward trend of PCT was a deviation due to small sample size. TNF-α is excreted by leukocytes and macrophages following recognition of an antigen. Its main function is to recruit additional leukocytes and monocytes in the blood and to increase the inflammatory process by increasing adhesion to the endothelium and secretion of molecules belonging to the complement system by the liver [14] . CRRT is considered as an adjunctive therapy in hypercytokinemia to remove excess cytokine due to the peak concentration hypothesis raised by prof. Ronco, rather than removing normal level of cytokine which may be beneficial to patients [15] . Since there was only one case with elevated initial concentration of TNF-α, and was sharply decreased after CRRT, while others' were normal in initially, the overall upward trend of TNF-α may also result from the small sample size and the low initial concentration.

In this study, we observed a significant improvement of hemodynamic among hemodynamically-instable patients after Oxiris-CRRT, which has already been widely confirmed by domestic and foreign researches [13, 14, 16, 17, 18] . However, the mechanism remains unclear. Researchers have found that the main manifestations of microcirculation disorder were leukocyte adhesion and plasma extravasation, which may explain the possible mechanism of shock in sepsis patients, namely, plasma extravasation caused a decrease in the effective circulation capacity [19] . It was showed in the study that reducing the level of overexpressed cytokines -such as IL-1β -through cytokine scavenging therapy, could induce a significant decrease in leukocyte adhesion and plasma extravasation, which lead to the improvement of microcirculation disorder [19] , indicated that overexpressed cytokine removal may contribute to improve hemodynamic status. However, this hypothesis needs to be explored further in larger studies. In addition, it should be noted that blood

This article is protected by copyright. All rights reserved lactate concentrations didn't decrease along with the improvement of hemohynamics, which indicated an oxygen utilization disorder of tissue and organ among critically ill Covid-19 patients.

Organ function, represented by SOFA score and APACHE II score, was improved significantly after treatment with Oxiris filter in our study, which was also showed in other studies among patients with hypercytokinemia such as sepsis [13, 18] , shows that CRRT has become a multiorgan support rather than pure renal replacement among these patients with the development of medical and membrane technology, and providing opportunity and condition for further treatment, which may improve patients' outcome. We found that even in condition of aggravated secondary infection or coagulation and fibrinolysin disorder, organ function could be staged approved with

Oxiris-CRRT, which shows a potentially benefit for critically ill Covid-19 patients.

There were several limitations to this study. First, it was just a descriptive research without control group due to the specificity of the disease. Second, it was a small sample size study which may lead to a deviation of the result.

In conclusion, our study observed a reduced level of overexpressed cytokines, stabilization of hemodynamic status, and staged improvement of organ function during the treatment with Oxiris filter.

This article is protected by copyright. All rights reserved 

This article is protected by copyright. All rights reserved 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention

Into the eye of the cytokine storm

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

oXirisNet registry: a prospective, national registry on the oXiris membrane

Continuous renal replacement therapy with the adsorbing filter oXiris in septic patients: a case series

Interpreting the Mechanisms of Continuous Renal Replacement Therapy in Sepsis: The Peak Concentration Hypothesis

oXiris® use in septic shock: experience of two French centres

Augmented Adsorptive Blood Purification During Continuous Veno-Venous Haemodiafiltration in a Severe Septic, Acute Kidney Injury Patient: Use of oXiris®: A Single Centre Case Report

Usage of oXiris hemofilter for septic shock patients: a single-center experience

Effects of Activated Protein C on the Mesenteric Microcirculation and Cytokine Release During Experimental Endotoxemia

This article is protected by copyright. All rights reserved Accepted Article